Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 19/20 | 0.76 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 11/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 7/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4850250 | 0.86 | HRH1 (1.00) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL4851203 | 0.86 | HRH1 (1.00) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL4849179 | 0.86 | HRH1 (1.00) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL6072944 | 0.85 | HRH1 (0.73) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL6072808 | 0.84 | HRH1 (0.57) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL6072724 | 0.82 | HRH1 (0.63) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL6072709 | 0.81 | HRH1 (0.74) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL6072666 | 0.79 | HRH1 (0.66) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL6072790 | 0.79 | HRH1 (0.76) | HRH1KCNH2CYP2D6CHRM1CYP3A4 | |
| SCHEMBL6072967 | 0.78 | HRH1 (0.75) | HRH1KCNH2CYP2D6CHRM1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006019497-A2 | SLEEP-INDUCING COMPOUNDS AND METHODS RELATED THERETO | NEUROCRINE BIOSCIENCES, INC. (US) | 2006-02-23 | — | — | WO | claimed |
| WO-2006019497-A2 | SLEEP-INDUCING COMPOUNDS AND METHODS RELATED THERETO | NEUROCRINE BIOSCIENCES, INC. (US) | 2006-02-23 | — | — | WO | disclosed |